38794716|t|Exogenous Ketone Supplement Administration Abrogated Isoflurane-Anesthesia-Induced Increase in Blood Glucose Level in Female WAG/Rij Rats.
38794716|a|It has been demonstrated that isoflurane-induced anesthesia can increase the blood glucose level, leading to hyperglycemia and several adverse effects. The administration of a mix of ketone diester (KE) and medium-chain triglyceride (MCT) oil, named KEMCT, abolished the isoflurane-anesthesia-induced increase in blood glucose level and prolonged the recovery time from isoflurane anesthesia in a male preclinical rodent model, Wistar Albino Glaxo/Rijswijk (WAG/Rij) rats. While most preclinical studies use exclusively male animals, our previous study on blood glucose changes in response to KEMCT administration showed that the results can be sex-dependent. Thus, in this study, we investigated female WAG/Rij rats, whether KEMCT gavage (3 g/kg/day for 7 days) can change the isoflurane (3%)-anesthesia-induced increase in blood glucose level and the recovery time from isoflurane-evoked anesthesia using the righting reflex. Moreover, KEMCT-induced ketosis may enhance both the extracellular level of adenosine and the activity of adenosine A1 receptors (A1Rs). To obtain information on the putative A1R mechanism of action, the effects of an A1R antagonist, DPCPX (1,3-dipropyl-8-cyclopentylxanthine; intraperitoneal/i.p. 0.2 mg/kg), on KEMCT-generated influences were also investigated. Our results show that KEMCT supplementation abolished the isoflurane-anesthesia-induced increase in blood glucose level, and this was abrogated by the co-administration of DPCPX. Nevertheless, KEMCT gavage did not change the recovery time from isoflurane-induced anesthesia. We can conclude that intragastric gavage of exogenous ketone supplements (EKSs), such as KEMCT, can abolish the isoflurane-anesthesia-induced increase in blood glucose level in both sexes likely through A1Rs in WAG/Rij rats, while recovery time was not affected in females, unlike in males. These results suggest that the administration of EKSs as an adjuvant therapy may be effective in mitigating metabolic side effects of isoflurane, such as hyperglycemia, in both sexes.
38794716	10	16	Ketone	Chemical	MESH:D007659
38794716	53	63	Isoflurane	Chemical	MESH:D007530
38794716	95	108	Blood Glucose	Chemical	MESH:D001786
38794716	128	132	/Rij	CellLine	
38794716	133	137	Rats	Species	10116
38794716	169	179	isoflurane	Chemical	MESH:D007530
38794716	216	229	blood glucose	Chemical	MESH:D001786
38794716	248	261	hyperglycemia	Disease	MESH:D006943
38794716	322	336	ketone diester	Chemical	-
38794716	338	340	KE	Chemical	-
38794716	346	373	medium-chain triglyceride (	Chemical	MESH:C000709826
38794716	373	381	MCT) oil	Chemical	-
38794716	389	394	KEMCT	Chemical	-
38794716	410	420	isoflurane	Chemical	MESH:D007530
38794716	452	465	blood glucose	Chemical	MESH:D001786
38794716	509	519	isoflurane	Chemical	MESH:D007530
38794716	606	610	rats	Species	10116
38794716	695	708	blood glucose	Chemical	MESH:D001786
38794716	732	737	KEMCT	Chemical	-
38794716	851	855	rats	Species	10116
38794716	865	870	KEMCT	Chemical	-
38794716	917	927	isoflurane	Chemical	MESH:D007530
38794716	964	977	blood glucose	Chemical	MESH:D001786
38794716	1011	1021	isoflurane	Chemical	MESH:D007530
38794716	1077	1082	KEMCT	Chemical	-
38794716	1091	1098	ketosis	Disease	MESH:D007662
38794716	1143	1152	adenosine	Chemical	MESH:D000241
38794716	1301	1306	DPCPX	Chemical	MESH:C051360
38794716	1308	1342	1,3-dipropyl-8-cyclopentylxanthine	Chemical	MESH:C051360
38794716	1380	1385	KEMCT	Chemical	-
38794716	1453	1458	KEMCT	Chemical	-
38794716	1489	1499	isoflurane	Chemical	MESH:D007530
38794716	1531	1544	blood glucose	Chemical	MESH:D001786
38794716	1603	1608	DPCPX	Chemical	MESH:C051360
38794716	1624	1629	KEMCT	Chemical	-
38794716	1675	1685	isoflurane	Chemical	MESH:D007530
38794716	1760	1766	ketone	Chemical	MESH:D007659
38794716	1795	1800	KEMCT	Chemical	-
38794716	1818	1828	isoflurane	Chemical	MESH:D007530
38794716	1860	1873	blood glucose	Chemical	MESH:D001786
38794716	1925	1929	rats	Species	10116
38794716	2131	2141	isoflurane	Chemical	MESH:D007530
38794716	2151	2164	hyperglycemia	Disease	MESH:D006943
38794716	Negative_Correlation	MESH:D001786	MESH:D007659
38794716	Positive_Correlation	MESH:D007530	MESH:D006943
38794716	Positive_Correlation	MESH:D000241	MESH:D007662
38794716	Negative_Correlation	MESH:D007530	MESH:D007659
38794716	Positive_Correlation	MESH:D001786	MESH:D007530

